Clinical trial
A Phase IV, Open-Label Safety Evaluation of the Effect of DEFINITY® on Pulmonary Artery Hemodynamics in Patients With Normal and Increased Pulmonary Artery Pressure
NCT00918866 is registered in ClinicalTrials.gov with Lantheus Medical Imaging as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IV, Open-Label Safety Evaluation of the Effect of DEFINITY® on Pulmonary Artery Hemodynamics in Patients With Normal and Increased Pulmonary Artery Pressure
- Lead sponsor
- Lantheus Medical Imaging
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- December 31, 2009
- Enrollment
- 32 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.